Literature DB >> 3924096

N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties.

D Andreu, R B Merrifield, H Steiner, H G Boman.   

Abstract

Six analogues of the 37-residue antibacterial peptide cecropin A were synthesized by the solid-phase method: cecropin A-(2-37), [Glu2]cecropin A, [Pro4]cecropin A, [Glu6]cecropin A, [Leu6]cecropin A, and [Pro8]cecropin A. Their antibacterial activities against four test organisms were determined and related to conformational changes observed in their CD spectra and were discussed on the basis of a previously proposed amphipathic alpha-helix model. An aromatic residue in position 2 was shown to be important for activity against all tested bacteria. The highly alpha-helical 1-11 region of cecropin A did not appear to play a significant role in its activity against Escherichia coli but was clearly involved in its interaction against Pseudomonas aeruginosa, Bacillus megaterium, and Micrococcus luteus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924096     DOI: 10.1021/bi00328a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities.

Authors:  K H Mayo; J Haseman; H C Young; J W Mayo
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study.

Authors:  Kalpana Bhargava; Jimmy B Feix
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

3.  Modeling the ion channel structure of cecropin.

Authors:  S R Durell; G Raghunathan; H R Guy
Journal:  Biophys J       Date:  1992-12       Impact factor: 4.033

Review 4.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

5.  Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus.

Authors:  W A Reed; P H Elzer; F M Enright; J M Jaynes; J D Morrey; K L White
Journal:  Transgenic Res       Date:  1997-09       Impact factor: 2.788

6.  A bactericidal cecropin-A peptide with a stabilized alpha-helical structure possess an increased killing capacity but no proinflammatory activity.

Authors:  Huamei Fu; Ase Björstad; Claes Dahlgren; Johan Bylund
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

7.  Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides.

Authors:  Rafael Ferre; Esther Badosa; Lidia Feliu; Marta Planas; Emili Montesinos; Eduard Bardají
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

8.  The expression of cecropin peptide in transgenic tobacco does not confer resistance to Pseudomonas syringae pv tabaci.

Authors:  R Hightower; C Baden; E Penzes; P Dunsmuir
Journal:  Plant Cell Rep       Date:  1994-02       Impact factor: 4.570

9.  Improved activity of a synthetic indolicidin analog.

Authors:  T J Falla; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

10.  Immobilization of Escherichia coli cells by use of the antimicrobial peptide cecropin P1.

Authors:  Kalvin Gregory; Charlene M Mello
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.